---
figid: PMC6899642__EJI-49-2051-g003
figlink: /pmc/articles/PMC6899642/figure/eji4604-fig-0003/
number: F3
caption: Schematic of the mevalonate pathway, showing the sites of action of statins
  and other inhibitors. Statins inhibit the conversion of 3‐hydroxy‐3‐methylglutaryl‐CoA
  (HMG‐CoA) to mevalonate and thus inhibit the downstream synthesis of not only cholesterol,
  but also isoprenoid intermediates, such as farnesyl pyrophosphate (FPP) and geranylgeranyl
  pyrophosphate (GGPP), which regulate posttranslational modifications of the small
  GTPase Ras and Rho families. Zaragozic acid A (ZAA), farnesyl transferase inhibitor
  FTI‐277, and geranylgeranyl transferase inhibitor GGTI‐298 block the synthesis pathways
  that split off from FPP in the mevalonate pathway. HA1077 blocks the pathway of
  Rho kinase (ROCK).
pmcid: PMC6899642
papertitle: Statins can suppress DC‐mediated Th2 responses through the repression
  of OX40‐ligand and CCL17 expression.
reftext: Noriko Inagaki‐Katashiba, et al. Eur J Immunol. 2019 Nov;49(11):2051-2062.
pmc_ranked_result_index: '56132'
pathway_score: 0.8672491
filename: EJI-49-2051-g003.jpg
figtitle: Schematic of the mevalonate pathway, showing the sites of action of statins
  and other inhibitors
year: '2019'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6899642__EJI-49-2051-g003.html
  '@type': Dataset
  description: Schematic of the mevalonate pathway, showing the sites of action of
    statins and other inhibitors. Statins inhibit the conversion of 3‐hydroxy‐3‐methylglutaryl‐CoA
    (HMG‐CoA) to mevalonate and thus inhibit the downstream synthesis of not only
    cholesterol, but also isoprenoid intermediates, such as farnesyl pyrophosphate
    (FPP) and geranylgeranyl pyrophosphate (GGPP), which regulate posttranslational
    modifications of the small GTPase Ras and Rho families. Zaragozic acid A (ZAA),
    farnesyl transferase inhibitor FTI‐277, and geranylgeranyl transferase inhibitor
    GGTI‐298 block the synthesis pathways that split off from FPP in the mevalonate
    pathway. HA1077 blocks the pathway of Rho kinase (ROCK).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FTL
  - PGGT1B
  - HRAS
  - KRAS
  - NRAS
  - RHO
  - ROCK2
  - ROCK1
  - RHOD
  - Acetyl-CoA
  - Statin
  - Mevalonate
  - Isopentyl
  - Geranyl
  - Farnesyl-PP Geranylgeranyl-PP
  - FPP
  - Squalene
  - GGPP
  - Cholesterol
genes:
- word: FTI
  symbol: FTL
  source: hgnc_symbol
  hgnc_symbol: FTL
  entrez: '2512'
- word: GGTI
  symbol: GGTI
  source: hgnc_alias_symbol
  hgnc_symbol: PGGT1B
  entrez: '5229'
- word: Ras)
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras)
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras)
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Rho)
  symbol: RHO
  source: hgnc_symbol
  hgnc_symbol: RHO
  entrez: '6010'
- word: ROCK
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK2
  entrez: '9475'
- word: ROCK
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK1
  entrez: '6093'
- word: Rho
  symbol: Rho
  source: hgnc_alias_symbol
  hgnc_symbol: RHOD
  entrez: '29984'
chemicals:
- word: Acetyl-CoA
  source: MESH
  identifier: D000105
- word: Statin
  source: MESH
  identifier: D019821
- word: Mevalonate
  source: MESH
  identifier: D008798
- word: Isopentyl
  source: MESH
  identifier: C029683
- word: Geranyl
  source: MESH
  identifier: C031049
- word: Farnesyl-PP Geranylgeranyl-PP
  source: MESH
  identifier: C466065
- word: FPP
  source: MESH
  identifier: C039834
- word: Squalene
  source: MESH
  identifier: D013185
- word: GGPP
  source: MESH
  identifier: C002963
- word: Cholesterol
  source: MESH
  identifier: D002784
diseases: []
figid_alias: PMC6899642__F3
redirect_from: /figures/PMC6899642__F3
figtype: Figure
---
